Sitemap

This Web site has been created solely for the purpose of providing information about services available from Richmond Pharmacology (RP). The site has been compiled in good faith from information available at the time and is therefore subject to change at any time and without notification.

Latest news

Statement on COVID-19

23rd Mar 2020

Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are

Read more ›

First transdermal patch to treat schizophrenia hits market

18th Mar 2020

The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia

Read more ›

Richmond Pharmacology supporting clinical facilities in Nicaragua

30th Jan 2020

Richmond Pharmacology have developed a resourceful way to use study equipment to help reduce waste produced on site

Read more ›

Cardiac Safety London

To help to enrich and speeding up your drug development programs, join us for a day of discovery as global experts

View event ›